Many studies reported good performance of nasopharyngeal swab-based antigen tests for detecting SARS-CoV-2-positive individuals; however, studies independently evaluating the quality of antigen tests utilizing anterior nasal swabs or saliva swabs are still rare, although such tests are widely used for mass testing. In our study, sensitivities, specificities and predictive values of seven antigen tests for detection of SARS-CoV-2 (one using nasopharyngeal swabs, two using anterior nasal swabs and four using saliva) were evaluated. In a setting of a high-capacity testing center, nasopharyngeal swabs for quantitative PCR (qPCR) were taken and, at the same time, antigen testing was performed in accordance with manufacturers' instructions for the respective tests. In samples where qPCR and antigen tests yielded different results, virus culture was performed to evaluate the presence of the viable virus. Sensitivities and specificities of individual tests were calculated using both qPCR and qPCR corrected for viability as the reference. In addition, calculations were also performed for data categorized according to the cycle threshold and symptomatic status. The test using nasopharyngeal swabs yielded the best results (sensitivity of 80.6% relative to PCR and 91.2% when corrected for viability) while none of the remaining tests (anterior nasal swab or saliva-based tests) came even close to the WHO criteria for overall sensitivity. Hence, we advise caution when using antigen tests with alternative sampling methods without independent validation.

Center for Health Research Faculty of Medicine University of Ostrava Syllabova 19 703 00 Ostrava Czech Republic

Department of Epidemiology and Public Health Faculty of Medicine University of Ostrava Syllabova 19 703 00 Ostrava Czech Republic

Department of Internal Medicine Faculty of Medicine University of Ostrava Syllabova 19 703 00 Ostrava Czech Republic

Hospital Karvina Raj Vydmuchov 399 734 01 Karvina Czech Republic

Institute of Public Health Ostrava Partyzánské náměstí 7 702 00 Ostrava Czech Republic

See more in PubMed

ECDC . Options for the Use of Rapid Antigen Tests for COVID-19 in the EU/EEA and the UK. ECDC; Solna Municipality, Sweden: 2020.

Brümmer L.E., Katzenschlager S., Gaeddert M., Erdmann C., Schmitz S., Bota M., Grilli M., Larmann J., Weigand M.A., Pollock N.R., et al. The accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis. medRxiv. 2021 doi: 10.1101/2021.02.26.21252546. PubMed DOI PMC

Dinnes J., Deeks J.J., Adriano A., Berhane S., Davenport C., Dittrich S., Emperador D., Takwoingi Y., Cunningham J., Beese S., et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst. Rev. 2020;8:CD013705. doi: 10.1002/14651858.cd013705. PubMed DOI PMC

Scheiblauer H., Filomena A., Nitsche A., Puyskens A., Corman V.M., Drosten C., Zwirglmaier K., Lange C., Emmerich P., Müller M., et al. Comparative sensitivity evaluation for 122 CE-marked SARS-CoV-2 antigen rapid tests. medRxiv. 2021 doi: 10.1101/2021.05.11.21257016. PubMed DOI PMC

ECDC ECDC Technical Report: Considerations Onthe Use of Self-Testsfor COVID-19 in the EU/EEA. [(accessed on 6 June 2021)]. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/Considerations-use-of-self-tests-for-COVID-19-in-the-EU-EEA-17-March2021-erratum.pdf.

Bastos M.L., Perlman-Arrow S., Menzies D., Campbell J.R. The sensitivity and costs of testing for SARS-CoV-2 infection with saliva versus nasopharyngeal swabs: A systematic review and meta-analysis. Ann. Intern. Med. 2021;174:501–510. doi: 10.7326/M20-6569. PubMed DOI PMC

Homza M., Zelena H., Janosek J., Tomaskova H., Jezo E., Kloudova A., Mrazek J., Svagera Z., Prymula R. Five antigen tests for SARS-CoV-2: Virus viability matters. Viruses. 2021;13:684. doi: 10.3390/v13040684. PubMed DOI PMC

Homza M., Zelena H., Janosek J., Tomaskova H., Jezo E., Kloudova A., Mrazek J., Svagera Z., Prymula R. Covid-19 antigen testing: Better than we know? A test accuracy study. Infect. Dis. 2021;53:1–8. doi: 10.1080/23744235.2021.1914857. PubMed DOI PMC

WHO . Antigen-Detection in the Diagnosis of SARS-CoV-2 Infection Using Rapid Immunoassays: Interim Guidance, 11 September 2020. World Health Organization; Geneva, Switzerland: 2020.

Bullard J., Dust K., Funk D., Strong J.E., Alexander D., Garnett L., Boodman C., Bello A., Hedley A., Schiffman Z., et al. Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples. Clin. Infect. Dis. 2020;71:2663–2666. doi: 10.1093/cid/ciaa638. PubMed DOI PMC

La Scola B., Le Bideau M., Andreani J., Hoang V.T., Grimaldier C., Colson P., Gautret P., Raoult D. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol. 2020;39:1059–1061. doi: 10.1007/s10096-020-03913-9. PubMed DOI PMC

Osmanodja B., Budde K., Zickler D., Naik M.G., Hofmann J., Gertler M., Hülso C., Rössig H., Horn P., Seybold J., et al. Accuracy of a novel SARS-CoV-2 antigen-detecting rapid diagnostic test from standardized self-collected anterior nasal swabs. J. Clin. Med. 2021;10:2099. doi: 10.3390/jcm10102099. PubMed DOI PMC

Nikolai O., Rohardt C., Tobian F., Junge A., Corman V.M., Jones T.C., Gaeddert M., Lainati F., Sacks J.A., Seybold J., et al. Anterior nasal versus nasal mid-turbinate sampling for a SARS-CoV-2 antigen-detecting rapid test: Does localisation or professional collection matter? medRxiv. 2021 doi: 10.1101/2021.02.09.21251274. PubMed DOI PMC

Pollock N.R., Jacobs J.R., Tran K., Cranston A.E., Smith S., O’Kane C.Y., Roady T.J., Moran A., Scarry A., Carroll M., et al. Performance and implementation evaluation of the abbott binaxnow rapid antigen test in a high-throughput drive-through community testing site in massachusetts. J. Clin. Microbiol. 2021;59:e00083-21. doi: 10.1128/JCM.00083-21. PubMed DOI PMC

Pilarowski G., Lebel P., Sunshine S., Liu J., Crawford E., Marquez C., Rubio L., Chamie G., Martinez J., Peng J., et al. Performance characteristics of a rapid severe acute respiratory syndrome coronavirus 2 antigen detection assay at a public plaza testing site in san francisco. J. Infect. Dis. 2021;223:1139–1144. doi: 10.1093/infdis/jiaa802. PubMed DOI PMC

James A.E., Gulley T., Kothari A., Holder K., Garner K., Patil N. Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) antigen card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees. Infect. Control Hosp. Epidemiol. 2021:1–3. doi: 10.1017/ice.2021.20. PubMed DOI PMC

Can variants, reinfection, symptoms and test types affect COVID-19 diagnostic performance? A large-scale retrospective study of AG-RDTs during circulation of Delta and Omicron variants, Czechia, December 2021 to February 2022